Forget the revenue, forget the backlog...can BE acquire the scandium oxide needed to build to the backlog capacity? This is needed to justify the multiple. That's what's keeping me out of BE, a stock I REALLY want to own... I wish KR would just address this directly!
I thought the response was: "visibility for 25GW of deployments, not China-dependent". That is not the same as naming a source. Are you satisfied with this?
Why should he give specifics on his supply chain? He's made statements that the SEC holds him and the company liable for. That should be good enough for you. Divulging the specifics of the supply chain introduces new type of risk that is just unnecessary. As a shareholder, I much prefer them retaining supply chain IP in this situation.
Bloom's obligation to disclose its Scandium oxide supply flows from general securities-law: public companies must disclose risks a "reasonable investor would consider important" to an investment decision, typically in 10-K risk-factor sections.
If a raw-material dependency like scandium is sourced largely from Asia/China THAT could materially affect production, costs, or the accuracy of prior investor statements, omitting or misstating it becomes a disclosure problem. They don't have to disclose supply chain IP to show country source is not China. Acknowledge this or not.. it is holding the stock back...
Forget the revenue, forget the backlog...can BE acquire the scandium oxide needed to build to the backlog capacity? This is needed to justify the multiple. That's what's keeping me out of BE, a stock I REALLY want to own... I wish KR would just address this directly!
he did. It’s a non issue
I thought the response was: "visibility for 25GW of deployments, not China-dependent". That is not the same as naming a source. Are you satisfied with this?
Bloom is his baby. He knows it better than anyone. This is his moment not going to mess it up. I believe him.
he did. It’s a non issue
Why should he give specifics on his supply chain? He's made statements that the SEC holds him and the company liable for. That should be good enough for you. Divulging the specifics of the supply chain introduces new type of risk that is just unnecessary. As a shareholder, I much prefer them retaining supply chain IP in this situation.
Bloom's obligation to disclose its Scandium oxide supply flows from general securities-law: public companies must disclose risks a "reasonable investor would consider important" to an investment decision, typically in 10-K risk-factor sections.
If a raw-material dependency like scandium is sourced largely from Asia/China THAT could materially affect production, costs, or the accuracy of prior investor statements, omitting or misstating it becomes a disclosure problem. They don't have to disclose supply chain IP to show country source is not China. Acknowledge this or not.. it is holding the stock back...